Crescent Grove Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Crescent Grove Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$0.17 - $1.19 $6,460 - $45,220	38,000 Added 172.73%	60,000 $21,000
Q4 2022 Jan 12, 2023	BUY	$0.74 - $1.83 $740 - $1,830	1,000 Added 4.76%	22,000 $0
Q3 2022 Nov 08, 2022	BUY	$1.51 - $2.88 $1,510 - $2,880	1,000 Added 5.0%	21,000 $33,000
Q1 2022 May 04, 2022	SELL	$2.0 - $4.9 $46,000 - $112,700	-23,000 Reduced 53.49%	20,000 $47,000
Q4 2021 Jan 24, 2022	BUY	$4.65 - $7.23 $97,650 - $151,830	21,000 Added 95.45%	43,000 $200,000
Q3 2021 Oct 26, 2021	BUY	$7.41 - $10.99 $14,820 - $21,980	2,000 Added 10.0%	22,000 $168,000
Q2 2021 Jul 26, 2021	BUY	$6.35 - $10.0 $127,000 - $200,000	20,000 New	20,000 $194,000

5.48M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Crescent Grove Advisors, LLC with notifications on news.